Accueil / Tag Archives: Massachusetts

Tag Archives: Massachusetts

InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jersey’s Cooper Neurological Institute

Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord …

Plus »

Eleven Biotherapeutics to Present at Oppenheimer’s 27th Annual Healthcare Conference

Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing a broad pipeline of novel product candidates based on its Targeting Protein Therapeutics (TPTs) platform, today announced that Stephen Hurly, President and Chief Executive Officer, will present a company overview …

Plus »

Poxel Announces Positive Results for Thorough QT Safety Clinical Study of Imeglimin

Tuesday, March 21st 2017 at 7:00am UTC LYON, France–(BUSINESS WIRE)– POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for type 2 diabetes, today announced that it has successfully completed a thorough QT/QTc (TQT) cardiac safety study on Imeglimin in 55 healthy …

Plus »

Cerulean and Daré to Host Conference Call on Proposed Transaction on March 23

Tuesday, March 21st 2017 at 1:38am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Cerulean Pharma Inc. (NASDAQ:CERU), today announced jointly with Daré Bioscience that the companies will hold a joint conference call to discuss the definitive share purchase agreement under which the stockholders of Daré Bioscience will become the majority owners of Cerulean. …

Plus »

Cerulean Pharma and Daré Bioscience Enter into Stock Purchase Agreement

Monday, March 20th 2017 at 12:00pm UTC Transaction to create NASDAQ-listed company focused on the development and commercialization of women’s reproductive health products Sabrina Martucci Johnson to be Named CEO of Combined Company Cerulean and Daré to Host Joint Conference Call in March to Discuss Proposed Transaction and Dare’s Business …

Plus »

ZOLL Receives Health Canada Approval for Two New Models Of AEDS

Tuesday, March 21st 2017 at 5:03pm UTC Expands Lifesaving Portfolio with Enhanced Real CPR Help and Program Management Onboard CHELMSFORD, Mass.–(BUSINESS WIRE)– ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that Health Canada has approved the ZOLL AED 3™* and …

Plus »

Variantyx Launches Genomic Intelligence® Clinical Diagnostic Platform

Tuesday, March 21st 2017 at 1:00pm UTC FRAMINGHAM, Mass.–(BUSINESS WIRE)– Variantyx announced the US launch of its proprietary clinical diagnostic platform at the American College of Medical Genetics (ACMG) conference in Phoenix, AZ. The Genomic Intelligence® platform automates the complete NGS testing process from sample collection to sequencing, data analysis, …

Plus »

Syros Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Monday, March 20th 2017 at 12:01pm UTC – Presented Data at Key Medical Meetings Further Supporting Therapeutic Potential of SY-1425 in Genomically Defined AML, MDS and Breast Cancer Patients – – Highlighted Data at Scientific Conferences Demonstrating Productivity of Syros’ Gene Control Platform in Oncology and Immuno-oncology – – On …

Plus »

Siamab Therapeutics to Present New Preclinical Data for Its Novel Antibodies and Antibody Drug Candidates at the American Association for Cancer Research Annual Meeting 2017

Tuesday, March 21st 2017 at 12:01pm UTC NEWTON, Mass.–(BUSINESS WIRE)– Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced it will present preclinical data for its novel anti-Sialyl-Tn (STn) and anti-CD3 bispecific antibodies and antibody drug candidates (ADCs) during two poster presentations at the American Association for …

Plus »

Cue Biopharma to Present at 5th Annual Cancer Biopartnering & Investment Forum

Tuesday, March 21st 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Cue Biopharma, Inc. (Cue), an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease, announced today that it will present at the 5th Annual Cancer Biopartnering & Investment Forum hosted by …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
Retrouvez nous sur
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...